Results 221 to 230 of about 24,769 (259)
Urgent X‐Rays in Children With Unexplained Haematemesis Help Rule Out Button Battery Ingestion
ABSTRACT Aim The ingestion of foreign bodies, particularly button batteries, is a significant concern in paediatric care, especially in children under 4 years of age. This study aims to review unwitnessed button battery ingestion in infants and toddlers, considering the serious complications and the higher risk in children under 2 years old.
Malni Irene+3 more
wiley +1 more source
Massive lower gastrointestinal hemorrhage due to primary internal iliac arterial-sigmoid colon fistula. [PDF]
Li Q, Wang H, Chen Z, Ni Z.
europepmc +1 more source
Prevalence of Asymptomatic Premalignant Oesophageal Lesions in Patients With Fanconi Anaemia
Clinically relevant endoscopic findings in asymptomatic Fanconi Anemia patients. ABSTRACT Fanconi anaemia (FA), a rare genetic disorder of DNA repair, predisposes to squamous cell carcinomas of head, neck and oesophagus. We assessed the value of screening esophagogastroduodenoscopy (EGD) in 20 asymptomatic adults (median age 23.5, 65% female) with FA ...
Joshua A. Sloan+7 more
wiley +1 more source
Diagnostic and therapeutic value of appendoscope-assisted endoscopic retrograde appendicitis therapy
Pengcheng Liu+4 more
doaj +1 more source
A recurrent multimodal sparse transformer framework for gastrointestinal disease classification. [PDF]
Sharmila V, Geetha S.
europepmc +1 more source
Objectives To evaluate the safety and efficacy of magnetic resonance imaging (MRI)‐guided transurethral ultrasound ablation (TULSA) as a minimally invasive alternative for benign prostatic obstruction (BPO). Patients and Methods This prospective, single‐centre, early phase II study (NCT03350529) included 30 men with BPO scheduled for primary ...
Antti Viitala+9 more
wiley +1 more source
Green Endoscopy: A Review of Global Perspectives on Environmental Sustainability of Gastrointestinal Endoscopy. [PDF]
Rao A+9 more
europepmc +1 more source
Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen+3 more
wiley +1 more source